Evaluation of Exudative Pleural Effusions: A Multicenter, Prospective, Observational Study.

Current diagnostic methods for exudative pleural effusions vary in effectiveness. Prior research has shown that pleural effusions can arise from multiple causes, including benign and malignant conditions. However, the ability to distinguish between these causes remains limited. No prior work had resolved the optimal combination of diagnostic procedures for accurate diagnosis. This gap motivated the need for a study to assess the performance of various diagnostic techniques. The uncertainty around which methods provide the best sensitivity and specificity for malignancy detection remains significant. Existing literature lacks data on how to reduce unnecessary interventions in benign cases. The absence of standardized criteria for benign effusion diagnosis complicates clinical decision-making. This study aimed to address these limitations by evaluating multiple diagnostic procedures in a large cohort.

This study aimed to evaluate the diagnostic performance of pleural procedures in undiagnosed exudative pleural effusions. The specific problem addressed was the need to distinguish between benign and malignant causes effectively. The motivation stemmed from the high prevalence of malignancy in such cases. The researchers sought to determine the sensitivity and accuracy of various diagnostic tools. They also aimed to identify factors that may suggest a benign or malignant etiology. The study focused on tertiary care centers to reflect real-world clinical settings. The goal was to improve diagnostic accuracy while minimizing unnecessary interventions. The results could inform clinical guidelines for managing pleural effusions.

The study was a multicenter, prospective, observational design. It included 777 patients with undiagnosed exudative pleural effusions. Participants were enrolled between January 1 and December 31, 2018. Diagnostic procedures such as cytology and image-guided pleural biopsy were evaluated. The researchers recorded the outcomes of these procedures and final diagnoses. Sensitivity, specificity, and accuracy were calculated with 95% confidence intervals. The study focused on how these metrics varied by effusion type and origin. The data were analyzed to compare the effectiveness of different diagnostic approaches.

Malignancy was the most common cause of exudative pleural effusions at 38.3%. Lung cancer accounted for 20.2% of all malignant cases. Cytology had a sensitivity of 59.5% and accuracy of 84.3% for malignancy detection. Image-guided pleural biopsy showed a higher sensitivity of 86.4%. Combining cytology with image-guided biopsy increased sensitivity to over 90%. Thoracoscopic biopsy provided the highest sensitivity at 94.3%. Cytology was most effective in breast cancer-related effusions with 86.7% sensitivity. These findings highlight the value of combining multiple diagnostic methods.

The study demonstrated that combining cytology with image-guided biopsy improves diagnostic sensitivity. Thoracoscopic biopsy showed the highest sensitivity for malignancy detection. The results suggest that these combined methods are more effective than cytology alone. However, the authors emphasized the need to avoid unnecessary procedures in benign cases. They proposed the development of criteria to identify benign effusions. This would help reduce complications and unnecessary interventions. The findings support the use of a multimodal diagnostic approach. The authors suggest that these results may inform future clinical guidelines.